Elos Medtech AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was SEK 233.1 million compared to SEK 181 million a year ago. Net income was SEK 29.7 million compared to SEK 18.4 million a year ago. Basic earnings per share from continuing operations was SEK 3.68 compared to SEK 2.28 a year ago.
For the six months, sales was SEK 427.6 million compared to SEK 352.2 million a year ago. Net income was SEK 52.7 million compared to SEK 38.4 million a year ago. Basic earnings per share from continuing operations was SEK 6.53 compared to SEK 4.76 a year ago.